Publications for Halina Dorot Halicka dorota_halicka@nymc.edu

NYMC Graduate School of Basic Medical Sciences
  • Amin, A. R., Karpowicz, P. A., Carey, T. E., Arbiser, J., Nahta, R., Chen, Z. G., . . . Halicka, D. (2015). Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in Cancer Biology, 35(Suppl), S55-S77. doi:10.1016/j.semcancer.2015.02.005

  • Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. , . . . Halicka, D. (2015). Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology, 35(Suppl), S276-S304. doi:10.1016/j.semcancer.2015.09.007

  • Casey, S. C., Amedei, A., Aquilano, K., Azmi, A. S., Benencia, F., Bhakta, D., . . . Halicka, D. (2015). Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology, 35(Suppl), S199-S223. doi:10.1016/j.semcancer.2015.02.007

  • Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., . . . Halicka, D. (2015). Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Seminars in Cancer Biology, 35(Suppl), S25-S54. doi:10.1016/j.semcancer.2015.02.006

  • Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G., Dasgupta, S., . . . Halicka, D. (2015). Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Seminars in Cancer Biology, 35(Suppl), S5-S24. doi:10.1016/j.semcancer.2015.03.005

  • Hanly, E. K., Bednarczyk, R. B., Moscatello, A. L., Halicka, H. D., Geliebter, J., Darzynkiewicz, Z., . . . Tiwari, R. K. (2015). mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. Oncotarget, 6(37), 39702-39713. doi:10.18632/oncotarget.4052

  • Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., . . . Halicka, D. (2015). Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Seminars in Cancer Biology, 35(Suppl), S244-S275. doi:10.1016/j.semcancer.2015.03.008

  • Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H. Y., Lin, L. T.,. . . Halicka, D (2015). Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology, 35(Suppl), S78-S103. doi:10.1016/j.semcancer.2015.03.001

  • Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., . . . Halicka, D.  (2015). Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Seminars in Cancer Biology, 35(Suppl), S185-S198. doi:10.1016/j.semcancer.2015.03.004

  • Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., . . . Halicka, D. (2015). Therapeutic targeting of replicative immortality. Seminars in Cancer Biology, 35(Suppl), S104-S128. doi:10.1016/j.semcancer.2015.03.007

  • Darzynkiewicz, Z., Zhao, H., Halicka, H. D., Li, J., Lee, Y. S., Hsieh, T. C., & Wu, J. M. (2014). In search of antiaging modalities: Evaluation of mTOR- and ROS/DNA damage-signaling by cytometry. Cytometry. Part A, 85(5), 386-399. doi:10.1002/cyto.a.22452

  • Stobezki, R., Titus, S., Halicka, D., Darzynkiewicz, Z., & Oktay, K. (2014). Declining DNA double strand break repair results in male reproductive aging. Fertility and Sterility, 102(3 Suppl.), e110.

  • Titus, S., Stobezki, R., Turan, V., Halicka, D., De Sutter, P., & Oktay, K. (2014). Sphingosine-1-phosphate, a protector against chemotherapy-induced ovarian follicle apoptosis does not diminish the effectiveness of chemotherapy. Fertility and Sterility, 102(3 Suppl.), e39

  • Zhao, H., Halicka, H. D., Li, J., & Darzynkiewicz, Z. (2013). Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging, 5(8), 623-636. PMCID: PMC3796215

  • Zhao, H., Halicka, H. D., Li, J., Biela, E., Berniak, K., Dobrucki, J., & Darzynkiewicz, Z. (2013). DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5-ethynyl-2'-deoxyuridine incorporated into DNA. Cytometry Part A, 83(11), 979-988. doi:10.1002/cyto.a.22327